The global hyperkalemia treatment market is anticipated to grow at a significant CAGR during the forecast period. The major factor for the growth of the market is the increasing chronic diseases such as acute hyperkalemia and chronic hyperkalemia due to other ailments such as diabetes, consumption of high potassium diets, and many other things. As per the National Kidney Foundation, more than 37 million people in the United States have CKDs annually.

According to the WHO, hyperkalemia is reported in around 5% population of the world annually. According to the National Kidney Foundation, the prevalence of hyperkalemia can be up to 20% suffering from heart and kidney disease can be up to 20%. For the treatment of hyperkalemia, potassium is considered one of the most effective treatments. It is used to treat this disease when present in acute and chronic states and advanced states across the globe. Because hyperkalemia is a disease that takes place when there is an elevation in the serum potassium, which happens due to disturbances in the body’s potassium levels.  Some of the key players in the global hyperkalemia supplements market include AstraZeneca PLC, Ardelyx, Vifor Pharma Management Ltd, Sanofi SA, Perrigo Company PLC, and many others. 

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered- 
• By Drug 
• By Type of disease
• Regions Covered 

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape-AstraZeneca PLC, Ardelyx, Vifor Pharma Management Ltd, Sanofi SA, Perrigo Company PLC, and many others. 

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Hyperkalemia Treatment Market by Segments

• By Drug

o Sodium Zirconium Cyclosilicate

o Beta2 Agonist

o Sodium Polystyrene Sulfonate

o Other Drugs

• By Type of Disease

o Acute Hyperkalemia

o Chronic Hyperkalemia

Global Hyperkalemia Treatment Market by Regions